| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinically relevant orthotopic implantation nude mouse model of human epithelial ovarian cancer—based on consecutive observation
|
Yi, X.F.
|
|
|
15 |
5 |
p. 850-855
|
artikel
|
| 2 |
Aggressive locally recurrent vulvar cancer: review of cases presented to Massachusetts General Hospital 1990 to present
|
Spiryda, L.B.
|
|
|
15 |
5 |
p. 884-889
|
artikel
|
| 3 |
Angiogenesis in gynecological oncology—mechanism of tumor progression and therapeutic targets
|
Rasila, K.K.
|
|
|
15 |
5 |
p. 710-726
|
artikel
|
| 4 |
A reappraisal on the management of lumbosacral plexopathies in gynecological malignancies: where do the physiatrists stand?
|
Özçakar, L.
|
|
|
15 |
5 |
p. 915-917
|
artikel
|
| 5 |
Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines
|
Kong, B.
|
|
|
15 |
5 |
p. 872-877
|
artikel
|
| 6 |
Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas
|
Saffari, B.
|
|
|
15 |
5 |
p. 952-963
|
artikel
|
| 7 |
Atypical glandular cells: improvement in cytohistologic correlation by the 2001 Bethesda system
|
Gurbuz, A.
|
|
|
15 |
5 |
p. 903-910
|
artikel
|
| 8 |
Brain metastases from epithelial ovarian cancer
|
Tay, S.K.
|
|
|
15 |
5 |
p. 824-829
|
artikel
|
| 9 |
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
|
Duffy, M.J.
|
|
|
15 |
5 |
p. 679-691
|
artikel
|
| 10 |
Cancer-associated serum antigen level: a novel prognostic indicator for survival in patients with recurrent ovarian carcinoma
|
Gronlund, B.
|
|
|
15 |
5 |
p. 836-843
|
artikel
|
| 11 |
Can local application of imiquimod cream be an alternative mode of therapy for patients with high-grade intraepithelial lesions of the vagina?
|
Haidopoulos, D.
|
|
|
15 |
5 |
p. 898-902
|
artikel
|
| 12 |
Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity
|
Kandel, M.J.
|
|
|
15 |
5 |
p. 780-784
|
artikel
|
| 13 |
Comparison of the results of surgical treatment using laparoscopy and laparotomy in patients with endometrial cancer
|
Sobiczewski, P.
|
|
|
15 |
5 |
p. 946-951
|
artikel
|
| 14 |
Dietary factors and endometrial cancer risk. Results of a case–control study in Mexico
|
Salazar-Martinez, E.
|
|
|
15 |
5 |
p. 938-945
|
artikel
|
| 15 |
Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study
|
Gordon, A.N.
|
|
|
15 |
5 |
p. 785-792
|
artikel
|
| 16 |
Efficacy and tolerability of lower-dose topotecan in recurrent ovarian cancer: a retrospective case review
|
Mitchell, S.K.
|
|
|
15 |
5 |
p. 793-798
|
artikel
|
| 17 |
Establishment and characterization of a human ovarian sarcomatoid carcinoma cell line BUPH: OVSC
|
Guo, H.F.
|
|
|
15 |
5 |
p. 856-865
|
artikel
|
| 18 |
Favorable clinical behavior in young ovarian carcinoma patients: a rationale for conservative surgery?
|
Sardi, J.E.
|
|
|
15 |
5 |
p. 762-769
|
artikel
|
| 19 |
Hormonal treatments and epithelial ovarian cancer risk
|
Auranen, A.
|
|
|
15 |
5 |
p. 692-700
|
artikel
|
| 20 |
Human papillomavirus infection: biology, epidemiology, and prevention
|
Scheurer, M.E.
|
|
|
15 |
5 |
p. 727-746
|
artikel
|
| 21 |
Ifosfamide-induced encephalopathy with or without using methylene blue
|
Park, I.S.
|
|
|
15 |
5 |
p. 807-810
|
artikel
|
| 22 |
Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in patients with stage I and II endometrial cancer
|
Kim, D.-Y.
|
|
|
15 |
5 |
p. 932-937
|
artikel
|
| 23 |
Microvessel density in ovarian carcinoma: computer image analysis in patients with shorter and longer survival
|
Raspollini, M.R.
|
|
|
15 |
5 |
p. 844-849
|
artikel
|
| 24 |
Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer
|
Chen, C.-H.
|
|
|
15 |
5 |
p. 878-883
|
artikel
|
| 25 |
Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis
|
Mangili, G.
|
|
|
15 |
5 |
p. 830-835
|
artikel
|
| 26 |
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies
|
Lê, L.H.
|
|
|
15 |
5 |
p. 799-806
|
artikel
|
| 27 |
Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma
|
Vergote, I.
|
|
|
15 |
5 |
p. 776-779
|
artikel
|
| 28 |
Positron emission tomography application for gynecologic tumors
|
Nakamoto, Y.
|
|
|
15 |
5 |
p. 701-709
|
artikel
|
| 29 |
Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1–2, stage IC endometrial cancer
|
Cengiz, M.
|
|
|
15 |
5 |
p. 926-931
|
artikel
|
| 30 |
Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer
|
Le, T.
|
|
|
15 |
5 |
p. 770-775
|
artikel
|
| 31 |
Profiling of proteins associated with cisplatin resistance in ovarian cancer cells
|
Zhu, K.
|
|
|
15 |
5 |
p. 747-754
|
artikel
|
| 32 |
Quality of life assessments in epithelial ovarian cancer patients during and after chemotherapy
|
Le, T.
|
|
|
15 |
5 |
p. 811-816
|
artikel
|
| 33 |
Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection
|
Mazzon, I.
|
|
|
15 |
5 |
p. 974-978
|
artikel
|
| 34 |
Response to the letter of Caluwaerts et al.
|
Baykal, C.e.m.
|
|
|
15 |
5 |
p. 988
|
artikel
|
| 35 |
Response to the letter of Van Calsterenet al.
|
Menczer Prof, Jose.p.h.
|
|
|
15 |
5 |
p. 985
|
artikel
|
| 36 |
Results of radiotherapy alone in the treatment of carcinoma of uterine cervix: a retrospective analysis of 1069 patients
|
Saibishkumar, E.P.
|
|
|
15 |
5 |
p. 890-897
|
artikel
|
| 37 |
Role of adnexectomy in the surgical treatment of cervical adenocarcinoma
|
Calsteren, K. Van
|
|
|
15 |
5 |
p. 984
|
artikel
|
| 38 |
Role of cyclin-dependent kinase p27 in uterine carcinosarcomas
|
Caluwaerts, S.
|
|
|
15 |
5 |
p. 986-987
|
artikel
|
| 39 |
Routine follow-up in cancer patients appears to bea precious ritual
|
Tjalma, W.A.A.
|
|
|
15 |
5 |
p. 993-994
|
artikel
|
| 40 |
Selective vessel ligation in the pelvis: an invaluable tool in certain surgical procedures
|
Sieunarine, K.
|
|
|
15 |
5 |
p. 967-973
|
artikel
|
| 41 |
The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients
|
Dijkstra, J.R.
|
|
|
15 |
5 |
p. 991-992
|
artikel
|
| 42 |
The contribution of spirituality and spiritual coping to anxiety and depression in women with a recent diagnosis of gynecological cancer
|
Boscaglia, N.
|
|
|
15 |
5 |
p. 755-761
|
artikel
|
| 43 |
The effects of ovulation induction on ovarian epithelium dysplasia scores and Ki67 expression: an experimental study on rats
|
Corakci, A.
|
|
|
15 |
5 |
p. 866-871
|
artikel
|
| 44 |
The Martius flap neovagina revisited
|
Green, A.E.
|
|
|
15 |
5 |
p. 964-966
|
artikel
|
| 45 |
The psychosocial impact of cervical cancer among affected women and their partners
|
De Groot, J.M.
|
|
|
15 |
5 |
p. 918-925
|
artikel
|
| 46 |
To the Editor:
|
Sliesoraitis, S.
|
|
|
15 |
5 |
p. 990
|
artikel
|
| 47 |
To the Editor:
|
Goldberg, A.
|
|
|
15 |
5 |
p. 989
|
artikel
|
| 48 |
Unusual location of ovarian mixed germ cell tumor
|
Ghaemmaghami, F.
|
|
|
15 |
5 |
p. 979-983
|
artikel
|
| 49 |
Urinary incontinence in gynecological oncology patients
|
Del Priore, G.
|
|
|
15 |
5 |
p. 911-914
|
artikel
|
| 50 |
Using logistic regression analysis in preliminary differential diagnosis of adnexal masses
|
Szpurek, D.
|
|
|
15 |
5 |
p. 817-823
|
artikel
|
Tijdschrift beschrijving